|Other names||Hypochondria, health anxiety (HA), illness anxiety disorder, somatic symptom disorder|
|Symptoms||Excessive and persistent fear of, or preoccupation with, having or developing a severe illness|
|Usual onset||Anytime from early childhood|
|Differential diagnosis||Actual serious medical condition, panic disorder, obsessive-compulsive disorder, generalized anxiety disorder|
|Treatment||Cognitive behavioral therapy (CBT)|
|Prognosis||~50% meet criteria after ~1-5 yrs|
Hypochondriasis or hypochondria is a condition in which a person is excessively and unduly worried about having a serious illness. An old concept, the meaning of hypochondria has repeatedly changed. It has been claimed that this debilitating condition results from an inaccurate perception of the condition of body or mind despite the absence of an actual medical diagnosis. An individual with hypochondriasis is known as a hypochondriac. Hypochondriacs become unduly alarmed about any physical or psychological symptoms they detect, no matter how minor the symptom may be, and are convinced that they have, or are about to be diagnosed with, a serious illness.
Often, hypochondria persists even after a physician has evaluated a person and reassured them that their concerns about symptoms do not have an underlying medical basis or, if there is a medical illness, their concerns are far in excess of what is appropriate for the level of disease. It is also referred to hypochondriaism which is the act of being in a hypochondriatic state, acute hypochondriaism. Many hypochondriacs focus on a particular symptom as the catalyst of their worrying, such as gastro-intestinal problems, palpitations, or muscle fatigue. To qualify for the diagnosis of hypochondria the symptoms must have been experienced for at least 6 months.
International Classification of Diseases (ICD-10) classifies hypochondriasis as a mental and behavioral disorder.  In the Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-TR defined the disorder, "Hypochondriasis", as a somatoform disorder and one study has shown it to affect about 3% of the visitors to primary care settings. The 2013 DSM-5 replaced the diagnosis of hypochondriasis with the diagnoses of somatic symptom disorder (75%) and illness anxiety disorder (25%).
Hypochondria is often characterized by fears that minor bodily or mental symptoms may indicate a serious illness, constant self-examination and self-diagnosis, and a preoccupation with one's body. Many individuals with hypochondriasis express doubt and disbelief in the doctors' diagnosis, and report that doctors’ reassurance about an absence of a serious medical condition is unconvincing, or short-lasting. Additionally, many hypochondriacs experience elevated blood pressure, stress, and anxiety in the presence of doctors or while occupying a medical facility, a condition known as "white coat syndrome". Many hypochondriacs require constant reassurance, either from doctors, family, or friends, and the disorder can become a debilitating challenge for the individual with hypochondriasis, as well as their family and friends. Some hypochondriacal individuals completely avoid any reminder of illness, whereas others frequently visit medical facilities, sometimes obsessively. Some sufferers may never speak about it.
Signs and symptoms
Hypochondriasis is categorized as a somatic amplification disorder—a disorder of "perception and cognition"—that involves a hyper-vigilance of situation of the body or mind and a tendency to react to the initial perceptions in a negative manner that is further debilitating. Hypochondriasis manifests in many ways. Some people have numerous intrusive thoughts and physical sensations that push them to check with family, friends, and physicians. For example, a person who has a minor cough may think that they have tuberculosis. Or sounds produced by organs in the body, such as those made by the intestines, might be seen as a sign of a very serious illness to patients dealing with hypochondriasis.
Other people are so afraid of any reminder of illness that they will avoid medical professionals for a seemingly minor problem, sometimes to the point of becoming neglectful of their health when a serious condition may exist and go undiagnosed. Yet others live in despair and depression, certain that they have a life-threatening disease and no physician can help them. Some consider the disease as a punishment for past misdeeds.
Hypochondriasis is often accompanied by other psychological disorders. Bipolar disorder, clinical depression, obsessive-compulsive disorder (OCD), phobias, and somatization disorder are the most common accompanying conditions in people with hypochondriasis, as well as a generalized anxiety disorder diagnosis at some point in their life.
Many people with hypochondriasis experience a cycle of intrusive thoughts followed by compulsive checking, which is very similar to the symptoms of obsessive-compulsive disorder. However, while people with hypochondriasis are afraid of having an illness, patients with OCD worry about getting an illness or of transmitting an illness to others. Although some people might have both, these are distinct conditions.
Patients with hypochondriasis often are not aware that depression and anxiety produce their own physical symptoms, and mistake these symptoms for manifestations of another mental or physical disorder or disease. For example, people with depression often experience changes in appetite and weight fluctuation, fatigue, decreased interest in sex, and motivation in life overall. Intense anxiety is associated with rapid heartbeat, palpitations, sweating, muscle tension, stomach discomfort, dizziness, shortness of breath, and numbness or tingling in certain parts of the body (hands, forehead, etc.).
If a person is ill with a medical disease such as diabetes or arthritis, there will often be psychological consequences, such as depression. Some even report being suicidal. In the same way, someone with psychological issues such as depression or anxiety will sometimes experience physical manifestations of these affective fluctuations, often in the form of medically unexplained symptoms. Common symptoms include headaches; abdominal, back, joint, rectal, or urinary pain; nausea; fever and/or night sweats; itching; diarrhea; dizziness; or balance problems. Many people with hypochondriasis accompanied by medically unexplained symptoms feel they are not understood by their physicians, and are frustrated by their doctors’ repeated failure to provide symptom relief.
The genetic contribution to hypochondriasis is probably moderate, with heritability estimates around 10-37%. Non-shared environmental factors (i.e., experiences that differ between twins in the same family) explain most of the variance in key components of the condition such as the fear of illness and disease conviction. In contrast, the contribution of shared environmental factors (i.e., experiences shared by twins in the same family) to hypochondriasis is approximately zero.
Although little is known about exactly which non-shared environmental factors typically contribute to causing hypochondriasis, certain factors such as exposure to illness-related information are widely believed to lead to short-term increases in health anxiety and to have contributed to hypochondriasis in individual cases. Overly protective caregivers and an excessive focus on minor health concerns have also been implicated as potential causes of hypochondriasis.
In the media and on the Internet, articles, TV shows, and advertisements regarding serious illnesses such as cancer and multiple sclerosis often portray these diseases as being random, obscure, and somewhat inevitable. In the short term, inaccurate portrayal of risk and the identification of non-specific symptoms as signs of serious illness may contribute to exacerbating fear of illness. Major disease outbreaks or predicted pandemics can have similar effects.
There is anecdotal evidence that it is common for serious illnesses or deaths of family members or friends to trigger hypochondria in certain individuals. Similarly, when approaching the age of a parent's premature death from disease, many otherwise healthy, happy individuals fall prey to hypochondria. These individuals believe they are suffering from the same disease that caused their parent's death, sometimes causing panic attacks with corresponding symptoms.
The ICD-10 defines hypochondriasis as follows:
- A. Either one of the following:
- A persistent belief, of at least six months' duration, of the presence of a minimum of two serious physical diseases (of which at least one must be specifically named by the patient).
- A persistent preoccupation with a presumed deformity or disfigurement (body dysmorphic disorder).
- B. Preoccupation with the belief and the symptoms causes persistent distress or interference with personal functioning in daily living and leads the patient to seek medical treatment or investigations (or equivalent help from local healers).
- C. Persistent refusal to accept medical advice that there is no adequate physical cause for the symptoms or physical abnormality, except for short periods of up to a few weeks at a time immediately after or during medical investigations.
- D. Most commonly used exclusion criteria: not occurring only during any of the schizophrenia and related disorders (F20–F29, particularly F22) or any of the mood disorders (F30–F39).
A. Preoccupation with fears of having, or the idea that one has, a serious disease based on the person's misinterpretation of bodily symptoms.
B. The preoccupation persists despite appropriate medical evaluation and reassurance.
C. The belief in Criterion A is not of delusional intensity (as in Delusional Disorder, Somatic Type) and is not restricted to a circumscribed concern about appearance (as in Body Dysmorphic Disorder).
D. The preoccupation causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
E. The duration of the disturbance is at least 6 months.
F. The preoccupation is not better accounted for by Generalized Anxiety Disorder, Obsessive-Compulsive Disorder, Panic Disorder, a Major Depressive Episode, Separation Anxiety, or another Somatoform Disorder.
The classification of hypochondriasis in relation to other psychiatric disorders has long been a topic of scholarly debate and has differed widely between different diagnostic systems and influential publications.
In the case of the DSM, the first and second versions listed hypochondriasis as a neurosis, whereas the third and fourth versions listed hypochondriasis as a somatoform disorder. The current version of the DSM (DSM-5) lists somatic symptom disorder (SSD) under the heading of "somatic symptom and related disorders", and illness anxiety disorder (IAD) under both this heading and as an anxiety disorder.
The ICD-10, like the third and fourth versions of the DSM, lists hypochondriasis as a somatoform disorder. The ICD-11, however, lists hypochondriasis under the heading of "obsessive-compulsive or related disorders".
There are also numerous influential scientific publications that have argued for other classifications of hypochondriasis. Notably, since the early 1990s, it has become increasingly common to regard hypochondriasis as an anxiety disorder, and to refer to the condition as "health anxiety" or "severe health anxiety".
Approximately 20 randomized controlled trials and numerous observational studies indicate that cognitive behavioral therapy (CBT) is an effective treatment for hypochondriasis. Typically, about two-thirds of patients respond to treatment, and about 50% of patients achieve remission, i.e., no longer suffer from hypochondriasis after treatment. CBT for hypochondriasis and health anxiety may be offered in various formats, including as face-to-face individual or group therapy, via telephone, or as guided self-help with information conveyed via a self-help book or online treatment platform. Effects are typically sustained over time.
There is also evidence that antidepressant medications such as selective serotonin reuptake inhibitors can reduce symptoms. In some cases, hypochondriasis responds well to antipsychotics, particularly the newer atypical antipsychotic medications.
Among the regions of the abdomen, the hypochondrium is the uppermost part. The word derives from the Greek term ὑποχόνδριος hypokhondrios, meaning "of the soft parts between the ribs and navel" from ὑπό hypo ("under") and χόνδρος khondros, or cartilage (of the sternum). Hypochondria in Late Latin meant "the abdomen".
The term hypochondriasis for a state of disease without real cause reflected the ancient belief that the viscera of the hypochondria were the seat of melancholy and sources of the vapor that caused morbid feelings.[self-published source?] Until the early 18th century, the term referred to a "physical disease caused by imbalances in the region that was below your rib cage" (i.e., of the stomach or digestive system). For example, Robert Burton's The Anatomy of Melancholy (1621) blamed it "for everything from 'too much spittle' to 'rumbling in the guts'".
Immanuel Kant discussed hypochondria in his 1798 book, Anthropology from a Pragmatic Point of View, like this:
The disease of the hypochondriac consists in this: that certain bodily sensations do not so much indicate a really existing disease in the body as rather merely excite apprehensions of its existence: and human nature is so constituted – a trait which the animal lacks – that it is able to strengthen or make permanent local impressions simply by paying attention to them, whereas an abstraction – whether produced on purpose or by other diverting occupations – lessens these impressions, or even effaces them altogether.
- Berrios GE (2001) Hypochondriasis. History of the Concept. In Starcevic V & Lipsitt DR (eds). Hypochondriasis. Oxford, Oxford University Press, pp3-20.
- Avia MD, Ruiz MA (2005). "Recommendations for the Treatment of Hypochondriac Patients". Journal of Contemporary Psychotherapy. 35 (3): 301–13. doi:10.1007/s10879-005-4322-3. S2CID 28529570.
- Kring AM, Davison GC, Neale JM, Johnson SL (2007). Abnormal Psychology with Cases (10th ed.). Wiley. ISBN 978-0-471-71260-2.[page needed]
- Goldberg RJ (2007). Practical Guide to the Care of the Psychiatric Patient. ISBN 978-0-323-03683-2.[page needed]
- Drs; Sartorius, Norman; Henderson, A.S.; Strotzka, H.; Lipowski, Z.; Yu-cun, Shen; You-xin, Xu; Strömgren, E.; Glatzel, J.; Kühne, G.-E.; Misès, R.; Soldatos, C.R.; Pull, C.B.; Giel, R.; Jegede, R.; Malt, U.; Nadzharov, R.A.; Smulevitch, A.B.; Hagberg, B.; Perris, C.; Scharfetter, C.; Clare, A.; Cooper, J.E.; Corbett, J.A.; Griffith Edwards, J.; Gelder, M.; Goldberg, D.; Gossop, M.; Graham, P.; Kendell, R.E.; Marks, I.; Russell, G.; Rutter, M.; Shepherd, M.; West, D.J.; Wing, J.; Wing, L.; Neki, J.S.; Benson, F.; Cantwell, D.; Guze, S.; Helzer, J.; Holzman, P.; Kleinman, A.; Kupfer, D.J.; Mezzich, J.; Spitzer, R.; Lokar, J. "The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines" (PDF). www.who.int World Health Organization. Microsoft Word. bluebook.doc. p. 116. Retrieved 23 June 2021 – via Microsoft Bing.
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revised, Washington, DC, APA, 2000.[page needed]
- Escobar JI, Gara M, Waitzkin H, Silver RC, Holman A, Compton W (May 1998). "DSM-IV hypochondriasis in primary care". General Hospital Psychiatry. 20 (3): 155–9. doi:10.1016/S0163-8343(98)00018-8. PMID 9650033.
- "DSM-5 redefines hypochondriasis - Mayo Clinic".
- Diagnostic and statistical manual of mental disorders : DSM-5 (5th ed.). American Psychiatric Association. 2013. p. 310. ISBN 9780890425541.
- Olatunji BO, Etzel EN, Tomarken AJ, Ciesielski BG, Deacon B (November 2011). "The effects of safety behaviors on health anxiety: an experimental investigation". Behaviour Research and Therapy. 49 (11): 719–28. doi:10.1016/j.brat.2011.07.008. PMID 21839987.
- Schacter DL, Gilbert DT, Wegner DM (2011). "Generalized Anxiety Disorder". Psychology (second ed.).
- "Illness Anxiety Disorder". National Center for Biotechnology Information, U.S. National Library of Medicine. Retrieved 2021-06-24.
- Fallon BA, Qureshi AI, Laje G, Klein B (September 2000). "Hypochondriasis and its relationship to obsessive-compulsive disorder". The Psychiatric Clinics of North America. 23 (3): 605–16. doi:10.1016/S0193-953X(05)70183-0. PMID 10986730.
- Barsky AJ (December 1992). "Hypochondriasis and obsessive compulsive disorder". The Psychiatric Clinics of North America. 15 (4): 791–801. doi:10.1016/S0193-953X(18)30209-0. PMID 1461796.
- Fallon, B. A.; Qureshi, A. I.; Laje, G.; Klein, B. (September 2000). "Hypochondriasis and its relationship to obsessive-compulsive disorder". The Psychiatric Clinics of North America. 23 (3): 605–616. doi:10.1016/s0193-953x(05)70183-0. ISSN 0193-953X. PMID 10986730.
- "NIMH » Depression Basics". www.nimh.nih.gov. Retrieved 2019-11-20.
- "NIMH » Anxiety Disorders". www.nimh.nih.gov. Retrieved 2019-11-20.
- "Mental Health | ADA". www.diabetes.org. Retrieved 2019-10-10.
- Gelenberg AJ (April 2000). "Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment". Primary Care Companion to the Journal of Clinical Psychiatry. 2 (2): 49–54. doi:10.4088/pcc.v02n0204. PMC 181205. PMID 15014583.
- "Illness Anxiety Disorder". The Lecturio Medical Concept Library. Retrieved 2021-06-24.
- Taylor S, Thordarson DS, Jang KL, Asmundson GJ (2006). "Genetic and environmental origins of health anxiety: a twin study". World Psychiatry. 5 (1): 47–50. PMC 1472263. PMID 16757996.
- "Hypochondriasis." CareNotes. Thomson Healthcare, Inc., 2011. Health Reference Center Academic. Retrieved April 5, 2012.[verification needed]
- "Illness Anxiety Disorder". National Center for Biotechnology Information, U.S. National Library of Medicine. Retrieved 2021-06-24.
- Olatunji BO, Kauffman BY, Meltzer S, Davis ML, Smits JA, Powers MB (July 2014). "Cognitive-behavioral therapy for hypochondriasis/health anxiety: a meta-analysis of treatment outcome and moderators". Behaviour Research and Therapy. 58: 65–74. doi:10.1016/j.brat.2014.05.002. PMID 24954212.
- Bouman TK (February 2014). "Psychological Treatments for Hypochondriasis: A Narrative Review". Current Psychiatry Reviews. 10 (1): 58–69. doi:10.2174/1573400509666131119010612.
- Cooper, Kate; Gregory, James D.; Walker, Ian; Lambe, Sinead; Salkovskis, Paul M. (March 2017). "Cognitive Behaviour Therapy for Health Anxiety: A Systematic Review and Meta-Analysis". Behavioural and Cognitive Psychotherapy. 45 (2): 110–123. doi:10.1017/S1352465816000527. ISSN 1352-4658. PMID 28229805.
- Axelsson, Erland; Hedman-Lagerlöf, Erik (2019-11-02). "Cognitive behavior therapy for health anxiety: systematic review and meta-analysis of clinical efficacy and health economic outcomes". Expert Review of Pharmacoeconomics & Outcomes Research. 19 (6): 663–676. doi:10.1080/14737167.2019.1703182. ISSN 1473-7167. PMID 31859542.
- Morriss, Richard; Patel, Shireen; Malins, Sam; Guo, Boliang; Higton, Fred; James, Marilyn; Wu, Mengjun; Brown, Paula; Boycott, Naomi; Kaylor-Hughes, Catherine; Morris, Martin (December 2019). "Clinical and economic outcomes of remotely delivered cognitive behaviour therapy versus treatment as usual for repeat unscheduled care users with severe health anxiety: a multicentre randomised controlled trial". BMC Medicine. 17 (1): 16. doi:10.1186/s12916-019-1253-5. ISSN 1741-7015. PMC 6343350. PMID 30670044.
- Axelsson, Erland; Andersson, Erik; Ljótsson, Brjánn; Hedman-Lagerlöf, Erik (August 2018). "Cost-effectiveness and long-term follow-up of three forms of minimal-contact cognitive behaviour therapy for severe health anxiety: Results from a randomised controlled trial". Behaviour Research and Therapy. 107: 95–105. doi:10.1016/j.brat.2018.06.002. hdl:10616/46521. PMID 29936239.
- Axelsson, Erland; Andersson, Erik; Ljótsson, Brjánn; Björkander, Daniel; Hedman-Lagerlöf, Maria; Hedman-Lagerlöf, Erik (2020). "Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety: A Randomized Noninferiority Clinical Trial". JAMA Psychiatry. 77 (9): 915–924. doi:10.1001/jamapsychiatry.2020.0940. PMC 7221860. PMID 32401286.
- Tyrer, P.; Wang, D.; Crawford, M.; Dupont, S.; Cooper, S.; Nourmand, S.; Lazarevic, V.; Philip, A.; Tyrer, H. (2020-03-16). "Sustained benefit of cognitive behaviour therapy for health anxiety in medical patients (CHAMP) over 8 years: a randomised-controlled trial". Psychological Medicine: 1–9. doi:10.1017/S003329172000046X. ISSN 0033-2917. PMID 32174296.
- Louw K, Hoare J, Stein DJ (February 2014). "Pharmacological Treatments for Hypochondriasis: A Review". Current Psychiatry Reviews. 10 (1): 70–4. doi:10.2174/1573400509666131119004750.
- Fallon, Brian A.; Ahern, David K.; Pavlicova, Martina; Slavov, Iordan; Skritskya, Natalia; Barsky, Arthur J. (August 2017). "A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis". American Journal of Psychiatry. 174 (8): 756–764. doi:10.1176/appi.ajp.2017.16020189. ISSN 0002-953X. PMC 5957509. PMID 28659038.
- Harth W, Gieler U, Kusnir D, Tausk FA (2008). "Hypochondriacal Delusions". Clinical Management in Psychodermatology. Springer. p. 36. ISBN 978-3-540-34718-7.
- "hypochondria (n.)". Etymonline. Retrieved 14 April 2015.
- Harvey S (February 21, 2010). "Hypochondria". The Virtual Linguist.[self-published source]
- Mann L (July 11, 2012). "New book tries to explain the roots of hypochondria". Chicago Tribune.
|Look up hypochondriasis in Wiktionary, the free dictionary.|